Marigo, Ilaria
Zilio, Serena
Desantis, Giacomo
Mlecnik, Bernhard
Agnellini, Andrielly H.R.
Ugel, Stefano
Sasso, Maria Stella
Qualls, Joseph E.
Kratochvill, Franz
Zanovello, Paola
Molon, Barbara
Ries, Carola H.
Runza, Valeria
Hoves, Sabine
Bilocq, Amélie M.
Bindea, Gabriela
Mazza, Emilia M.C.
Bicciato, Silvio
Galon, Jérôme
Murray, Peter J.
Bronte, Vincenzo
Funding for this research was provided by:
Institut National Du Cancer
National Institutes of Health (CA138064)
National Institutes of Health (CA189990)
Labex Immuno-Oncology
Alex's Lemonade Stand Foundation for Childhood Cancer
Hartwell Foundation (P30 CA21765)
Ministero della Salute
Associazione Italiana per la Ricerca sul Cancro (12182)
Associazione Italiana per la Ricerca sul Cancro (14103)
Associazione Italiana per la Ricerca sul Cancro (2009NREAT2_003)
Associazione Italiana per la Ricerca sul Cancro (6599)
American Lebanese Syrian Associated Charities
Institut National de la Santé et de la Recherche Médicale
Austrian Science Fund (J3309-B19)
Fondazione Cassa di Risparmio di Padova e Rovigo
Qatar National Research Fund (NPRP09-1174-3-291)
This article is maintained by: Elsevier
Article Title: T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells
Journal Title: Cancer Cell
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ccell.2016.08.004
Content Type: article
Copyright: © 2016 Elsevier Inc.